Free Trial

APG Asset Management US Inc. Sells 2,193 Shares of Danaher Co. (NYSE:DHR)

Danaher logo with Medical background

APG Asset Management US Inc. lowered its holdings in Danaher Co. (NYSE:DHR - Free Report) by 14.0% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,432 shares of the conglomerate's stock after selling 2,193 shares during the quarter. APG Asset Management US Inc.'s holdings in Danaher were worth $3,083,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. boosted its position in shares of Danaher by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate's stock valued at $13,715,641,000 after purchasing an additional 315,912 shares during the period. Geode Capital Management LLC increased its stake in shares of Danaher by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate's stock valued at $3,056,996,000 after acquiring an additional 315,446 shares during the last quarter. Norges Bank purchased a new position in shares of Danaher in the 4th quarter worth about $2,130,740,000. Bank of New York Mellon Corp increased its holdings in Danaher by 5.4% in the 4th quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate's stock valued at $1,971,609,000 after purchasing an additional 441,012 shares in the last quarter. Finally, Fisher Asset Management LLC grew its holdings in Danaher by 0.6% during the 4th quarter. Fisher Asset Management LLC now owns 4,578,945 shares of the conglomerate's stock valued at $1,051,097,000 after purchasing an additional 26,305 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

DHR has been the topic of several analyst reports. Robert W. Baird dropped their target price on Danaher from $277.00 to $268.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. Stifel Nicolaus raised Danaher from a "hold" rating to a "buy" rating and set a $260.00 price objective for the company in a research note on Friday, March 14th. Citigroup reissued a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Scotiabank assumed coverage on shares of Danaher in a report on Monday, December 23rd. They set a "sector perform" rating and a $265.00 price target for the company. Finally, Wells Fargo & Company decreased their price objective on Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Four analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $276.57.

Read Our Latest Report on Danaher

Danaher Trading Up 1.7 %

NYSE:DHR traded up $3.16 on Monday, reaching $191.89. 1,327,349 shares of the company's stock were exchanged, compared to its average volume of 3,311,765. The business has a fifty day moving average of $203.71 and a 200-day moving average of $229.58. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The firm has a market capitalization of $137.15 billion, a price-to-earnings ratio of 36.34, a price-to-earnings-growth ratio of 2.66 and a beta of 0.86. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business posted $2.09 earnings per share. As a group, analysts expect that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Friday, March 28th. This is a positive change from Danaher's previous quarterly dividend of $0.27. Danaher's dividend payout ratio is currently 24.24%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Further Reading

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines